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Abstract
Background/Aim. Atrial fibrillation (AF) is the most com-
mon sustained cardiac arrhythmia in general population. The
aim of the study was to compare all-cause mortality and car-
diovascular mortality in patients with lone and idiopathic AF to
correspondent mortality in general population of Serbia.
Methods. A longitudinal observational study included the pa-
tients with nonvalvular AF as the main indication for in-
hospital and/or outpatient treatment in the Clinical Center of
Serbia, during a period 1992–2007, if the latest date of first di-
agnosed AF was early January 2003; in that way, the total fol-
low-up could last at least 5 years (minimum 1 year prospec-
tively), or until death. Principles of oral anticoagulation, heart
rhythm and frequency control during the study period were
conducted according to the latest international guidelines for
diagnosis and treatment of AF in the study period. Lone and
idiopathic AF were defined as AF in patients without any un-
derlying disease, younger than 60 years (lone AF) or older
(idiopathic AF). To compare mortality of the study population
with mortality of general population we used the standardized
mortality ratio (SMR) and chi-square test with p < 0.05 as a
level of statistical significance. Results. Out of 442 patients
with AF and no underlying disease, aged 47 ± 12.6 years, with
mean follow-up of 11.5 ± 7.2 years, 12 patients (2.7%) died: 7
patients of non-cardiovascular causes and 5 patients (1.1%) of
cardiovascular death. When compared to the general popula-
tion of Serbia, all-cause mortality and cardiovascular mortality
in the patients with lone and idiopathic AF were not higher
than in general population (p < 0.05). Conclusion. All-cause
mortality and cardiovascular mortality of patients with lone and
idiopathic AF are similar to all-cause mortality and cardiovas-
cular mortality in general population of Serbia.
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Apstrakt
Uvod/Cilj. Atrijalna fibrilacija (AF) je najčešći poreme-
ćaj srčanog ritma u opštoj populaciji. Cilj ovog rada  bio
je poređenje ukupnog i kardiovaskularnog mortaliteta
bolesnika sa lone i idiopatskom AF sa ukupnim i kardio-
vaskularnim mortalitetom opšte populacije Srbije. Me-
tod. Longitudinalnim opservacionim istraživanjem bili su
obuhvaćeni bolesnici ambulantno i/ili bolnički lečeni
zbog nevalvularne AF u Kliničkom centru Srbije u perio-
du 1992–2007, praćeni najmanje pet godina (i to prospe-
ktivno bar godinu dana) ili do smrtnog ishoda. Principi
primene oralne antikoagulantne terapije, kontrole ritma i
kontrole frekvencije srca usklađivani su sa najnovijim
međunarodnim preporukama za dijagnostiku i lečenje AF
u datom periodu studije. Lone i idiopatska AF definisane
su kao AF kod osoba bez pridruženog srčanog ili drugog
oboljenja, mlađih, odnosno starijih od 60 godina.  Za po-
ređenje ukupnog i kardiovaskularnog mortaliteta studij-
ske populacije sa mortalitetom stanovništva Srbije koriš-
ćen je χ2 test slaganja, uz nivo značajnosti od p < 0,05.
Rezultati. Od 442 bolesnika sa AF bez pridruženog
oboljenja, prosečne starosti 47 ± 12,6 godina, sa proseč-
nim praćenjem 11,5 ± 7,2 godine, 12 bolesnika (2,7%) je
umrlo: sedam bolesnika od nekardiovaskularnih uzroka i
pet (1,1%) kardiovaskularnom smrću. Poređenje ukup-
nog i kardiovaskularnog mortaliteta bolesnika sa lone i
idiopatskom AF sa odgovarajućim mortalitetom ukupne
populacije Srbije pokazalo je da nema statistički značajne
razlike između njih (p < 0,05). Zaključak. Bolesnici sa
lone i idiopatskom AF imaju sličan mortalitet kao ukupna
populacija Srbije.
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Introduction
Atrial fibrillation (AF) is the most common sustained
cardiac arrhythmia in general population
 1. However, AF is a
heterogeneous disorder, with variable origin, clinical pres-
entation and natural history. In the majority of patients, AF is
accompanied by underlying heart disease, most frequently
arterial hypertension. On the other hand, up to 30% of AF
patients may be free of any known structural cardiopulmon-
ary disease
 1–4. Lone AF is defined as AF in otherwise
healthy individuals not older than 60 years; if a patient is
older than 60 years and has no underlying disease, AF is
designated as idiopathic
 4.
While the Framingham Heart Study identified AF as an
independent predictor of increased risk of mortality, and the
Paris Prospective Study found idiopathic AF to be associated
with higher mortality compared to controls during a long-
term follow-up, several clinical studies found lone and idio-
pathic AF to have similar overall survival as general popula-
tion
 5–10.
The aim of the present study was to compare all-cause
mortality and cardiovascular mortality of patients with lone
and idiopathic AF with correspondent mortality in general
population of Serbia.
Methods
This longitudinal observational study included patients
with nonvalvular AF as main indication for in-hospital
and/or outpatient treatment in the Cardiology Clinic of In-
stitute for Cardiovascular Diseases, Clinical Center of Ser-
bia, during a period 1992–2007. The patients were included
in the study if the latest date of their first diagnosed AF was
early January 2003; in that way, a total follow-up lasted at
least 5 years, with a minimum of 1 year of prospective fol-
low-up, or until death.
The patients with acute causes of AF, advanced left
ventricular systolic dysfunction (LVEF  ≤ 25%),  preextita-
tion, known malignancy or any advanced chronic disease and
the patients with poorly documented history of previous AF
were not included in the study.
Diagnosis and treatment of AF were conducted ac-
cording to the international standards valid in the given pe-
riod of the study. The basic therapeutic approach throughout
the whole study was to make every reasonable effort to re-
store and maintain sinus rhythm whenever possible. The
principles of oral anticoagulation, rhythm control and fre-
quency control during the study period were applied accord-
ing to the latest international guidelines for diagnosis and
treatment of AF in that study period.
Classification to lone and idiopathic AF was subse-
quently reexamined at the end of the study, based on
ACC/AHA/ESC Guidelines on AF from 2006. After a de-
tailed review of medical records of each patient in the study
population, reclassification of AF was performed when
needed.
A cause of death was obtained from medical records
(hospital discharge letter, death certificate) combined with a
detailed interview with a closest family member when death
occurred out of hospital. A cause of death was subsequently
classified according to EHRA (European Heart and Rhythm
Association) classification, recently proposed for future
studies on AF
 11. Data on all-cause mortality and cardiovas-
cular mortality of general population of Serbia for the period
1992–2006 were acquired from National Institute for Health
Protection.
Continuous variables are shown as mean value ± stan-
dard deviation (SD). Categorical variables are given as
counts with percentages. To compare mortality of the study
population with mortality of general population we used
standardized mortality ratio (SMR) and chi-square test with
p < 0.05 as a level of statistical significance value, similarly
to previously published papers
 5–10.
Results
Out of 1 100 patients with nonvalvular AF, included in
the study, 442 patients (40.2%) had AF without underlying
disease: 377 patients (34.3%) were not older than 60 years,
i.e. they had lone AF, while 65 patients (5.9%) had idio-
pathic AF.
The mean follow-up of the patients with lone and idio-
pathic AF was 11.5 ± 7.2 years. Baseline clinical and echo-
cardiographic characteristics of these patients are shown in
Table 1. The majority of patients had paroxysmal AF and
normal left atrial anteroposterior diameter at baseline. How-
ever, in 1.1% of the patients AF was accompanied with tran-
sitory symptoms and signs of heart failure, despite normal
left ventricular diameters and normal left ventricular systolic
function.
Table 1
Baseline clinical and echocardiographic characteristics of
the patients with lone and idiopathic atrial fibrilation (AF)
Patients (n = 442)
Baseline characteristics
n%
Age (years), mean ± SD 47.0 ± 12.6
Paroxysmal AF 296 67
Persistent AF 94 21.3
Permanent AF 52 11.8
Left atrium ≤ 40 mm 348 78.7
Tachyaf at presentation 377 85.3
Heart failure at presentation 5 1.1
Asymptomatic presentation of AF 63 14.3
Events recorded during the follow-up, including all-
cause mortality and cardiovascular mortality are shown in
Table 2. Transition to permanent AF occurred in slightly
more than one third of patients with intermittent AF. The de-
velopment of a new cardiac disease was documented in one
forth of the patients with lone and idiopathic AF. The annual
rates of any thromboembolic event, stroke and transitory is-
chemic episodes were quite low (0.44%, 0.21% and 0.18%,
respectively), as well as the annual rates of all-cause mortal-
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Table 2
Events recorded during the follow-up
Patients (n = 442) Events during the follow-up n%
Progression to permanent AF* 128 32
Any thromboembolic event 21 4.8
Stroke 10 2.3
Transitory ischemic episode 9 2
New cardiac diseases 111 25.2
Hypertension 79 17.9
Coronary heart disease 7 1.6
Dilated cardiomyopathy 36 8.1
Tachycardiomyopathy 28 6.3
Heart failure 11 2.5
All-cause mortality 12 2.7
Cardiovascular mortality 5 1.1
*128/390 patients with intermittent (paroxysmal or persistent)
atrial fibrilation (AF) at baseline
Overall, 12 patients with lone and idiopathic AF died
during the follow-up (2.7% of 442 patients with lone and idio-
pathic AF). Seven patients died of non-cardiovascular causes
(4 patients from malignancy, 2 patients accidentally, 1 patient
of chronic non-cardiac disease), while in 5 patients death was
cardiovascular (2 patients died suddenly – one of them with
clear evidence of acute myocardial infarction, 1 patient died of
progressive congestive heart failure that occurred during the
follow-up, 1 patient died of stroke and 1 patient died immedi-
ately after cardiac by-pass grafting surgery).
When compared to general population of Serbia, all-
cause mortality and cardiovascular mortality in patients with
lone and idiopathic AF did not significantly differ from cor-
respondent expected mortalities, i.e. they were similar to all-
cause mortality (Figure 1) and cardiovascular mortality in
general population of Serbia (Figure 2).
Discussion
The main finding of the present study is that all-cause
mortality and cardiovascular mortality of patients with lone
and idiopathic AF in our study, after the mean follow-up of
11 years, were similar to correspondent mortalities in general
population of Serbia. This is in concord with the findings in
the population of 76 patients with lone AF reported by Ja-
hangir et al. 
10 after the mean follow-up of 25 years. How-
ever, our study population was almost 6 times larger than
their study population.
On the other hand, the Framingham Heart Study found
AF to be an independent risk factor for mortality in general
population with overt cardiac disease, and proposed that in-
creased mortality was a direct consequence of AF, even in
the absence of pre-existing cardiovascular disease
 5. How-
ever, Framingham study population was much older than our
study population (mean 73.7 years vs. mean 47 years). Pa-
tients in the Paris Prospective Study had a similar mean age
to our study population, but there were only 25 patients with
AF and no underlying disease. These patients had similar
non-cardiovascular death rate to controls, and higher cardio-
vascular death and all-cause death rates
 6.
The rates of transition to permanent AF, any thrombo-
embolic event, stroke, all-cause mortality and cardiovascular
mortality in our study population were quite similar to already
mentioned study of Jahangir et al. 
10. Moreover, these investi-
gators found that risk of adverse events in patients with lone
AF increases with age or the development of hypertension.
There are more than a few reports suggesting that the
risk of cardiovascular events in lone AF, including death, is
age dependent and increases significantly with the develop-
ment of hypertension, diabetes mellitus, congestive heart
failure and coronary heart disease
 12–16. In our study popula-
tion, almost 2/3 of deaths were non-cardiovascular, while the
majority of cardiovascular deaths could be attributed to the
development of new cardiovascular diseases during the fol-
low-up. A post hoc analysis of ELAT Study, where the pri-
mary endpoint was the assessment of thromboembolic risk in
AF patients, revealed that all-cause mortality of patients with
AF was 1.4 times higher than mortality of general popula-
tion, mainly because of the concomitant congestive heart
failure. Stollberger et al. 
17 concluded that prognosis of pa-
tients with AF highly depends on underlying cardiovascular
comorbidity. A similar conclusion was driven from the re-
sults of SCAF study, when all-cause mortality of patients
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Fig. 1 – All-cause mortality in the patients with lone and
idiopathic atrial fibrilation (AF), and in general population
of Serbia.
Fig. 2 – Cardiovascular mortality in the patients with lone
and idiopathic atrial fibrilation, and in general population of
Serbia.Volumen 67, Broj 2 VOJNOSANITETSKI PREGLED Strana 135
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with paroxysmal AF was analyzed
 18. We have also previ-
ously reported that all-cause mortality and cardiovascular
mortality in overall population of AF patients are higher than
such mortalities in general population of Serbia
 19. Obvi-
ously, active treatment of present cardiovascular diseases
and, even more importantly, prevention of development of
new cardiovascular diseases during the follow-up can sig-
nificantly improve the prognosis of patients with AF.
This study is subject to limitations inherent in observa-
tional studies and selection bias is an important considera-
tion. Although this was a non-directed study and a choice of
AF treatment was left to a responsible doctor, we believe that
a tertiary nature of our hospital ensured a proper decision-
making, which makes our study comparable to other similar
investigations. On the other hand, a tertiary center experience
may not completely reflect the overall treatment approach
and a long-term outcome of patients with lone and idiopathic
AF in clinical practice.
Conclusion
All-cause mortality and cardiovascular mortality of
patients with lone and idiopathic AF are similar to all-cause
mortality and cardiovascular mortality in general popula-
tion of Serbia. However, active treatment of rhythm disor-
der and proper prevention of complications of AF are nec-
essary. Moreover, patients with lone and idiopathic AF
need close monitoring for prevention or early recognition
of the development of new cardiovascular diseases during
follow-up.
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